Literature DB >> 19259080

Pathogenesis of and unifying hypothesis for idiopathic pouchitis.

J Calvin Coffey1, Fiachra Rowan, John Burke, Neil G Dochery, Neil Dochery, William O Kirwan, P Ronan O'Connell.   

Abstract

Ileal pouch-anal anastomosis is the procedure of choice in the surgical management of refractory ulcerative colitis. Pouchitis affects up to 60% of patients following ileal pouch-anal anastomosis for ulcerative colitis. It overlaps significantly with ulcerative colitis such that improvements in our understanding of one will impact considerably on the other. The symptoms are distressing and impinge significantly on patients' quality of life. Despite 30 years of scientific and clinical investigation, the pathogenesis of pouchitis is unknown; however, recent advances in molecular and cell biology make a synergistic hypothesis possible. This hypothesis links interaction between epithelial metaplasia, changes in luminal bacteria (in particular sulfate-reducing bacteria), and altered mucosal immunity. Specifically, colonic metaplasia supports colonization by sulfate-reducing bacteria that produce hydrogen sulfide. This causes mucosal depletion and subsequent inflammation. Although in most cases antibiotics lead to bacterial clearance and symptom resolution, immunogenetic subpopulations can develop a chronic refractory variant of pouchitis. The aims of this paper are to discuss proposed pathogenic mechanisms and to describe a novel mechanism that combines many hypotheses and explains several aspects of pouchitis. The implications for the management of both pouchitis and ulcerative colitis are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259080     DOI: 10.1038/ajg.2008.127

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  18 in total

1.  A shift from colon- to ileum-predominant bacteria in ileal-pouch feces following total proctocolectomy.

Authors:  Manami Hinata; Atsushi Kohyama; Hitoshi Ogawa; Sho Haneda; Kazuhiro Watanabe; Hideyuki Suzuki; Chikashi Shibata; Yuji Funayama; Ken-Ichi Takahashi; Iwao Sasaki; Kouhei Fukushima
Journal:  Dig Dis Sci       Date:  2012-04-27       Impact factor: 3.199

Review 2.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

3.  Understanding the pouch microbiota: an evolving story.

Authors:  Laura Harrell Raffals
Journal:  Dig Dis Sci       Date:  2012-11       Impact factor: 3.199

4.  Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.

Authors:  Jeffrey D McCurdy; Edward V Loftus; William J Tremaine; Thomas C Smyrk; David H Bruining; Darrell S Pardi; Laura E Raffals; John B Kisiel; Nayantara Coelho-Prabhu; Sunanda V Kane; William A Faubion; Konstantinos A Papadakis
Journal:  Inflamm Bowel Dis       Date:  2013-10       Impact factor: 5.325

5.  Synchronous cytomegalovirus and Clostridium difficile infection of the pouch: a trigger for chronic pouchitis?

Authors:  Ioannis Papaconstantinou; Evanthia Zampeli; Dionysios Dellaportas; Charalambos Giannopoulos; Maria Sotiropoulou; George Polymeneas; Giorgos Bamias; Spyros Michopoulos
Journal:  Clin J Gastroenterol       Date:  2014-02-14

Review 6.  Festschrift for Ronan O'Connell: pouchitis, ulcerative colitis and the microbiome.

Authors:  Aonghus Lavelle
Journal:  Ir J Med Sci       Date:  2018-03-09       Impact factor: 1.568

Review 7.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

8.  FK506-Binding Protein 5 mRNA Levels in Ileal Mucosa Are Associated with Pouchitis in Patients with Ulcerative Colitis.

Authors:  Toshimitsu Araki; Mikio Kawamura; Koji Tanaka; Yoshiki Okita; Hiroyuki Fujikawa; Keiichi Uchida; Yuji Toiyama; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Dig Dis Sci       Date:  2015-01-18       Impact factor: 3.199

Review 9.  Emerging drugs for the treatment of ulcerative colitis.

Authors:  Luca Pastorelli; Theresa T Pizarro; Fabio Cominelli; Maurizio Vecchi
Journal:  Expert Opin Emerg Drugs       Date:  2009-09       Impact factor: 4.191

Review 10.  Contributions of the microbial hydrogen economy to colonic homeostasis.

Authors:  Franck Carbonero; Ann C Benefiel; H Rex Gaskins
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-15       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.